{"id":18390,"date":"2021-06-25T10:45:09","date_gmt":"2021-06-25T14:45:09","guid":{"rendered":"https:\/\/medicarereport.org\/?p=18390"},"modified":"2021-06-25T10:45:09","modified_gmt":"2021-06-25T14:45:09","slug":"why-drug-price-negotiation-has-staying-power","status":"publish","type":"post","link":"https:\/\/medicarereport.org\/?p=18390","title":{"rendered":"Why Drug Price Negotiation Has Staying Power"},"content":{"rendered":"<p>(By\u00a0Drew Altman for Kaiser Family Foundation, published June 25, 2021)<\/p>\n<p>The fact that prescription drugs represent just 10% of national health spending may make it seem like not an especially important target for health care cost containment efforts. But the idea keeps coming back and is in the spotlight on Capitol Hill right now.\u00a0 Continue reading the article <a href=\"https:\/\/www.kff.org\/health-costs\/perspective\/why-drug-price-negotiation-has-staying-power\/\">here&#8230;<\/a><\/p>\n<p><a href=\"https:\/\/medicarereport.org\/wp-content\/uploads\/2017\/07\/Kaiser-Family-Foundation.jpg\"><img loading=\"lazy\" decoding=\"async\" class=\"alignnone size-full wp-image-7499\" src=\"https:\/\/medicarereport.org\/wp-content\/uploads\/2017\/07\/Kaiser-Family-Foundation.jpg\" alt=\"\" width=\"147\" height=\"138\" \/><\/a><\/p>\n<pre><strong>Notice:<\/strong> The link provided above connects readers to the full content of the posted article. The URL (internet address) for this link is valid on the posted date; medicarereport.org cannot guarantee the duration of the link\u2019s validity. Also, the opinions expressed in these postings are the viewpoints of the original source and are not explicitly endorsed by AMAC, Inc.; the AMAC Foundation, Inc.; or medicarereport.org<\/pre>\n","protected":false},"excerpt":{"rendered":"<p>(By\u00a0Drew Altman for Kaiser Family Foundation, published June 25, 2021) The fact that prescription drugs represent just 10% of national<\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[21,15],"tags":[],"class_list":["post-18390","post","type-post","status-publish","format-standard","hentry","category-health-care-finance","category-part-dprescription-drugs"],"_links":{"self":[{"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/posts\/18390","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/medicarereport.org\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=18390"}],"version-history":[{"count":1,"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/posts\/18390\/revisions"}],"predecessor-version":[{"id":18391,"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/posts\/18390\/revisions\/18391"}],"wp:attachment":[{"href":"https:\/\/medicarereport.org\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=18390"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/medicarereport.org\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=18390"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/medicarereport.org\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=18390"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}